Eli Lilly and Company (LLY)

[TechandBio]

GSK pays 2 Billion for Boston Pharma a IV LLY should scoop up SGMT the oral with the breakthrough designation.

MDGL just partnered with SGMT combining one oral tablet makes MDGL THR Beta work 80% compared to 25% alone Plus works incredibly well with GLP1 data with semaglutide & SGMT oral enhanced efficacy tremendously with SGMT Fatty synthesis the only one in the clinic world wide. SGMT has breakthrough designation for their phase 3 ready Mash Trials and Pediatric Mash the only in the clinic phase 2 Ready for Pediatric


$LLY